Alembic Pharmaceuticals

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue1,6651,7021,7841,7171,917
Expenses1,4981,5251,5911,5271,695
EBITDA256.01269.72286.11287.85322.60
EBIT199.23200.04216.46213.63247.95
Profit Before Tax180.42177.78191.94190.11223.72
Net Profit153.14137.70156.63153.63183.71
Financial Ratios
Operating Profit Margin16.37%15.96%16.13%16.80%16.96%
Net Profit Margin8.70%8.18%8.87%9.02%9.67%
Earning Per Share (Diluted)7.797.017.987.859.40
Dividends Per Share0.000.000.000.000.00